Century Therapeutics, Inc. (52)
Browse by Contract Category
Contracts
-
Research Collaboration and License Agreement, by and between Century Therapeutics, Inc. and Bristol-Myers Squibb Company, dated January 7, 2022
(Filed With SEC on March 17, 2022)
-
Letter Agreement by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated January 7, 2022
(Filed With SEC on March 17, 2022)
-
Securities Purchase Agreement, by and between Century Therapeutics, Inc. and Bristol-Myers Squibb Company, dated January 7, 2022
(Filed With SEC on January 10, 2022)
-
License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018
(Filed With SEC on June 15, 2021)
-
2021 Equity Incentive Plan
(Filed With SEC on June 14, 2021)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 17, 2022)
-
License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018
(Filed With SEC on June 15, 2021)
-
2021 Employee Stock Purchase Plan
(Filed With SEC on June 14, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on June 14, 2021)
-
Specimen Common Stock Certificate of Registrant
(Filed With SEC on June 14, 2021)
-
Executive Employment Agreement, by and between the Registrant and Luis Borges, Ph.D., datedMay 26, 2021
(Filed With SEC on June 14, 2021)
-
Executive Employment Agreement, by and between the Registrant and Adrienne Farid, Ph.D., dated May 26, 2021
(Filed With SEC on June 14, 2021)
-
Executive Employment Agreement, by and between the Registrant and Gregory Russotti, Ph.D., dated
(Filed With SEC on June 14, 2021)
-
License Agreement, by and among the Governing Council of the University of Toronto, the McMaster University and Empirica Therapeutics, dated January 22, 2019
(Filed With SEC on May 28, 2021)
-
Offer Letter, by and between the Registrant and Alessandro Riva, M.D., dated May 19, 2021
(Filed With SEC on May 28, 2021)
-
Offer Letter, by and between the Registrant and Kimberly Blackwell, M.D., dated May 19, 2021
(Filed With SEC on May 28, 2021)
-
Offer Letter, by and between the Registrant and Cynthia Butitta, dated February 25, 2021
(Filed With SEC on May 28, 2021)
-
Offer Letter, by and between the Registrant and Joseph Jimenez, dated February 16, 2021
(Filed With SEC on May 28, 2021)
-
Executive Employment Agreement, by and between the Registrant and Gregory Russotti, Ph.D., dated
(Filed With SEC on May 28, 2021)
-
Executive Employment Agreement, by and between the Registrant and Adrienne Farid, Ph.D., dated May 26, 2021
(Filed With SEC on May 28, 2021)
-
Executive Employment Agreement, by and between the Registrant and Luis Borges, Ph.D., datedMay 26, 2021
(Filed With SEC on May 28, 2021)
-
Executive Employment Agreement, by and between the Registrant and Hyam Levitsky, M.D., dated May 26, 2021
(Filed With SEC on May 28, 2021)
-
Executive Employment Agreement, by and between the Registrant and Michael Diem, M.D., dated May 26, 2021
(Filed With SEC on May 28, 2021)
-
Executive Employment Agreement, by and between the Registrant and Osvaldo Flores, Ph.D., dated May 26, 2021
(Filed With SEC on May 28, 2021)
-
License Agreement, by and between Inscripta, Inc. and Century Therapeutics, Inc., dated January 1, 2019
(Filed With SEC on May 28, 2021)
-
Investors Rights Agreement, by and among the Registrant and each of the investors listed on Schedule A thereto, dated February 25, 2021
(Filed With SEC on May 28, 2021)
-
Warrant to Purchase Units of Century Therapeutics, LLC, in favor of Hercules Technology Management Co II, Inc., dated September 14, 2020
(Filed With SEC on May 28, 2021)
-
Form of Stock Option Grant Notice and Award Agreement, under the 2021 Plan
(Filed With SEC on May 28, 2021)
-
Form of Indemnification Agreement by and between the Registrant and its individual directors and officers
(Filed With SEC on May 28, 2021)
-
2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Amendment No. 1 to 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Amendment No. 2 to 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Amendment No. 3 to 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Amendment No. 4 to 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Amendment No. 5 to 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Form of Restricted Stock Award Agreement, under the 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Form of Non-Qualified Stock Option Agreement, under the 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Form of Incentive Stock Option Agreement, under the 2018 Stock Option and Grant Plan
(Filed With SEC on May 28, 2021)
-
Form of Restricted Stock Unit Grant Notice and Award Agreement, under the 2021 Plan
(Filed With SEC on May 28, 2021)
-
Loan and Security Agreement, by and between Century Therapeutics, Inc. and Hercules Capital, Inc
(Filed With SEC on May 28, 2021)
-
Amended and Restated Option Agreement, by and between Century Therapeutics, Inc. and Bayer HealthCare LLC, dated February 25, 2021
(Filed With SEC on May 28, 2021)
-
Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated October 21, 2019
(Filed With SEC on May 28, 2021)
-
Amendment No. 1 to Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated July 17, 2020
(Filed With SEC on May 28, 2021)
-
Amendment No. 2 to Master Collaboration Agreement by and between Century Therapeutics, Inc. and
(Filed With SEC on May 28, 2021)
-
Amendment No. 3 to Master Collaboration Agreement by and between Century Therapeutics, Inc. and
(Filed With SEC on May 28, 2021)
-
Letter Agreement, by and among Century Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc. and Wisconsin Alumni Research Foundation, dated July 2, 2019
(Filed With SEC on May 28, 2021)
-
License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018
(Filed With SEC on May 28, 2021)
-
Amendment No. 1 to License Agreement (Differentiation), by and between Century Therapeutics, Inc
(Filed With SEC on May 28, 2021)
-
License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018
(Filed With SEC on May 28, 2021)
-
Amendment No. 1 to License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated March 23, 2021
(Filed With SEC on May 28, 2021)
-
Manufacturing and Supply Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated March 23, 2021
(Filed With SEC on May 28, 2021)
-
Sublicense Agreement, by and between iCELL Inc. and Century Therapeutics, Inc., dated March 20, 2020
(Filed With SEC on May 28, 2021)